Diabetic Neuropathy, Painful Terminated Phase 3 Trials for Desvenlafaxine (DB06700)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01050218Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral NeuropathyTreatment